| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2004;78:999-1002
© 2004 The Society of Thoracic Surgeons
a Division of Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan
Accepted for publication April 1, 2004.
* Address reprint requests to Dr Watanabe, Division of Thoracic Surgery, National Cancer Center Hospital, Tokyo 104-0045, Japan
syuwatan{at}ncc.go.jp
BACKGROUND: Changes in the postoperative mortality rates and causes of death for lung cancer surgery at the specialized hospital for cancer in Tokyo, Japan during the last 16 years were investigated.
METHODS: Data on 3,270 consecutive patients who underwent pulmonary resection for primary lung cancer between January 1987 and December 2002 at the National Cancer Center Hospital were retrospectively analyzed. The postoperative 30-day and in-hospital mortality rates and causes of death after pulmonary resection for lung cancer were investigated. Patients were divided into two period groups of almost equal number, the early (1,615 patients from 1987 to 1996) and the late (1,655 patients from 1997 to 2002) periods.
RESULTS: Fifty-eight operative and postoperative deaths occurred during the last 16 years. Thirty-day and in-hospital mortality were 0.6% (21/3,270) and 1.6% (58/3,270), respectively. During the last 6-year period, 30-day and in-hospital mortality were 0.5% (8/1,655) and 0.8% (21/1,655), respectively. The difference was significant between the 30-day/in-hospital mortality for pneumonectomy (3.1%/5.9%) and lobectomy (0.3%/1.3%) (p < 0.0001/p < 0.0001). The difference in mortality between lobectomy and segmentectomy or a lesser resection was not significant. The 58 deaths were caused by pneumonia/acute respiratory distress syndrome (ARDS) (36%, n = 21), bronchopleural fistula (BPF)/empyema (33%, n = 19), cerebrovascular accident (10%, n = 6), cardiac-related event (7%, n = 4), and others (14%, n = 8). The most frequent cause of death in the early period was BPF/empyema (18/45, 40%), while that in the late period was pneumonia/ARDS (6/13, 46%). Among the pneumonia/ARDS deaths in the late period (n = 6), 5 (83%) were due to acute deterioration of interstitial lung disease after lobectomy.
CONCLUSIONS: Recent postoperative mortality rates (30-day, 0.5%; in-hospital, 0.8%) in the treatment of lung cancer are quite acceptable. Special care must be taken for the patient after pneumonectomy, as reported by others. Furthermore, even after lobectomy, proper management of the patient with acute deterioration of interstitial lung disease will be required to improve the future outcome.
Related Article
Ann. Thorac. Surg. 2004 78: 1002-1003.
This article has been cited by other articles:
|
|
 |
|
  M. Licker, J.-M. Tschopp, J. Robert, J.-G. Frey, J. Diaper, and C. Ellenberger Aerosolized Salbutamol Accelerates the Resolution of Pulmonary Edema After Lung Resection Chest, April 1, 2008; 133(4): 845 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-E. Strand, H. Rostad, R. A M Damhuis, and J. Norstein Risk factors for 30-day mortality after resection of lung cancer and prediction of their magnitude Thorax, November 1, 2007; 62(11): 991 - 997. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Alam, B. J. Park, A. Wilton, V. E. Seshan, M. S. Bains, R. J. Downey, R. M. Flores, N. Rizk, V. W. Rusch, and D. Amar Incidence and Risk Factors for Lung Injury After Lung Cancer Resection Ann. Thorac. Surg., October 1, 2007; 84(4): 1085 - 1091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Scott, J. Howington, S. Feigenberg, B. Movsas, and K. Pisters Treatment of Non-small Cell Lung Cancer Stage I and Stage II: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 234S - 242S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Memtsoudis, M. C. Besculides, L. Zellos, N. Patil, and S. O. Rogers Trends in lung surgery: United States 1988 to 2002. Chest, November 1, 2006; 130(5): 1462 - 1470. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Maniwa, Y. Saito, H. Kaneda, and H. Imamura Bronchial stump reinforcement with the intercostal muscle flap without adverse effects. Eur. J. Cardiothorac. Surg., October 1, 2006; 30(4): 652 - 656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T-E Strand, H Rostad, B Moller, and J Norstein Survival after resection for primary lung cancer: a population based study of 3211 resected patients Thorax, August 1, 2006; 61(8): 710 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Feller-Kopman, R. Bechara, R. Garland, A. Ernst, and S. Ashiku Use of a removable endobronchial valve for the treatment of bronchopleural fistula. Chest, July 1, 2006; 130(1): 273 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Schussler, M. Alifano, H. Dermine, S. Strano, A. Casetta, S. Sepulveda, A. Chafik, S. Coignard, A. Rabbat, and J.-F. Regnard Postoperative Pneumonia after Major Lung Resection Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1161 - 1169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Matsubara, S.-i. Takeda, and T. Mashimo Risk Stratification for Lung Cancer Surgery: Impact of Induction Therapy and Extended Resection Chest, November 1, 2005; 128(5): 3519 - 3525. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Lauwers, J. Hendriks, and P. Van Schil Lobectomy of the right lower lobe for lung cancer MMCTS, June 28, 2005; 2005(0628): 59. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hendriks, P. Lauwers, and P. Van Schil Extrapericardial pneumonectomy MMCTS, June 28, 2005; 2005(0628): 83. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-i. Watanabe, H. Asamura, K. Suzuki, and R. Tsuchiya Problems in Diagnosis and Surgical Management of Clinical N1 Non-small Cell Lung Cancer Ann. Thorac. Surg., May 1, 2005; 79(5): 1682 - 1685. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
